scholarly journals Lobular capillary haemangioma of nasal septum with remodelling of bony lateral wall

Biomedicine ◽  
2021 ◽  
Vol 41 (2) ◽  
pp. 318-320
Author(s):  
Dosemane Deviprasad ◽  
Varshney Pallavi ◽  
Suresh Pooja ◽  
Khadilkar Meera Niranjan

The diagnosis of intranasal masses can often be confusing due to the diversity of inflammatory and neoplastic lesions affecting the sinonasal tract, and the ambiguity of symptoms. Haemangiomas have been described in head and neck. However, uncommon findings such as bony remodelling and unusual clinical appearance of mass were noted in the present case. The description of such non-classical presentations is essential in deciding further management and preventing plausible hemodynamic imbalance.

2017 ◽  
Vol 7 (1) ◽  
pp. 1127-1129
Author(s):  
A Ghosh ◽  
G Ghartimagar ◽  
S Thapa ◽  
MK Shrestha ◽  
OP Talwar

Extracranial meningiomas may be subdivided into primary and secondary types based on absence or presence of intracranial attachments respectively. Primary sinonasal tract meningiomas are rare with unknown etiopathology and non-specific clinical presentation. Of these PEMs only 11.5% are in the nasal cavity and nasal septum. To our knowledge less than 50 cases of PEM of nasal cavity have been reported in the literature. We report a case of a 22 years old male who presented with epistaxis and increasing nasal stuffiness for the last one year.


2013 ◽  
Vol 4 (1) ◽  
pp. 57-58
Author(s):  
Sagaya Raj ◽  
Shuaib Merchant ◽  
Azeem Mohiyuddin ◽  
P Arun

ABSTRACT Aims To describe an unusual presentation of myxoid liposarcoma of oropharynx and a brief review of literature. Introduction Liposarcomas of head and neck are very rare. Its treatment and prognosis mainly depends on the site and the histologic pattern of the tumor. Case presentation The present case report describes a 65-year-old male with complaints of dysphagia, dyspnea, and a peculiar complaint of mass in the throat which turned out to be a low-grade myxoid liposarcoma arising from right lateral wall of oropharynx extending intraluminal in the esophagus, compressing posterior wall of trachea. The mass was successfully excised surgically and postoperative period was uneventful and patient was asymptomatic 4 months after surgery. Conclusion Myxoid liposarcoma is a rare tumor in head and neck and surgical excision with adequate margin is the treatment of choice. How to cite this article Mohiyuddin A, Raj S, Merchant S, Arun P. Interesting Clinical Presentation of Myxoid Liposarcoma of Oropharynx. Int J Head and Neck Surg 2013;4(1):57-58.


1999 ◽  
Vol 41 (5) ◽  
pp. 369-375 ◽  
Author(s):  
P. Tortori-Donati ◽  
M. P. Fondelli ◽  
A. Rossi ◽  
G. L. Bava

Viruses ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 172 ◽  
Author(s):  
Mikołaj Wołącewicz ◽  
Rafał Becht ◽  
Ewelina Grywalska ◽  
Paulina Niedźwiedzka-Rystwej

Head and neck cancers arise in the mucosa lining the oral cavity, oropharynx, hypopharynx, larynx, sinonasal tract, and nasopharynx. The etiology of head and neck cancers is complex and involves many factors, including the presence of oncogenic viruses. These types of cancers are among the most common cancers in the world. Thorough knowledge of the pathogenesis of viral infections is needed to fully understand their impact on cancer development.


2004 ◽  
Vol 118 (8) ◽  
pp. 655-658 ◽  
Author(s):  
K. Madhumita ◽  
K.P. Sreekumar ◽  
H. Malini ◽  
R. Indudharan

A case of lobular capillary haemangioma of the trachea is presented. The patient gave a history of foreign body sensation in the throat and multiple episodes of haemoptysis. The chest X-ray was normal. A spiral computed tomograph (CT) with three-dimensional reconstruction revealed a small tracheal mass in the antero-lateral wall of the trachea, which was excised by endoscopy. The histopathological diagnosis was lobular capillary haemangioma, a rare, benign tumour of the trachea. A high index of suspicion with the spiral CT finding was responsible for early diagnosis of the tumour.


1999 ◽  
Vol 113 (5) ◽  
pp. 483-485 ◽  
Author(s):  
P. Jassar ◽  
N. D. Stafford ◽  
A. W. MacDonald

AbstractPleomorphic adenoma is the commonest benign tumour of the major salivary glands. It can also occur in minor salivary glands, mainly in the oral cavity, but also in other sites in the head and neck both within and outwith the upper aerodigestive tract. We present a rare case of pleomorphic adenoma of the nasal septum with consideration of the clinical management and a review of the literature.


1995 ◽  
Vol 16 (4) ◽  
pp. 272-275 ◽  
Author(s):  
Gregory E. Hyde ◽  
C. Thomas Yarington ◽  
Felix W.K. Chu

2014 ◽  
Vol 3 (1) ◽  
Author(s):  
Bestari J Budiman ◽  
Ricki Octiza

AbstrakCapillary haemangioma is a benign, rapidly growing lesion of the skin and mucous membranes. It may rarely present as a mass of considerable size and thus entirely fill the nasal cavity. Its etiology remains obscure. Capillary haemangioma usually involves the gingiva, lips, tongue, and buccal mucosa. However, the nasal cavity is a rare location for this lesion. The most common symptoms are unilateral epistaxis and nasal obstruction. The treatment of choice is surgery to remove the tumour even for large lesion. A case of capillary haemangioma at anterior nasal septal in 6 years old girl had been treated with extirpation.Kata kunci: Capillary haemangioma, nasal septum, epistaxis, diagnosis, treatmentAbstractHaemangioma kapiler merupakan suatu lesi jinak pada kulit dan mukosa dengan pertumbuhan yang cepat. Meskipun jarang berukuran besar, namun dapat memenuhi seluruh kavum nasi. Etiologinya sampai sekarang masih belum jelas. Haemangioma kapiler sering terdapat pada ginggiva, bibir, lidah dan mukosa bukal. Kavum nasi merupakan lokasi yang jarang terdapatnya haemangioma kapiler. Gejala yang paling sering adalah unilateral epistaksis dan sumbatan hidung. Pembedahan untuk mengangkat tumor ini merupakan terapi pilihan meskipun berukuran besar. Suatu kasus haemangioma kapiler septum anterior pada anak perempuan berumur 6 tahun telah dilakukan ekstirpasi sebagai terapi.Keywords: Haemangioma kapiler, septum nasi, epistaksis, diagnosis, penatalaksanaan


2013 ◽  
Vol 2 (37) ◽  
pp. 7038-7041
Author(s):  
Narve V.P. ◽  
Manish Kumar Sachan ◽  
Kavish Jhawar ◽  
Rajveer Basu ◽  
Freni J.K

2021 ◽  
Author(s):  
Claudia Lill ◽  
Boban Erovic ◽  
Rudolf Seemann ◽  
Muhammad Faisal ◽  
Klaus Stelter ◽  
...  

Abstract Purpose The purpose of the present study was to assess whether European head and neck cancer centers perform elective neck dissection (END) in early stage sinonasal squamous cell carcinomas (SCCs) and whether END affects oncological outcome. Methods A questionnaire regarding performance of END in T1 - T2 sinonasal SCCs was sent to 38 head and neck cancer centers in Europe. The results were further correlated and compared with clinical data of 58 patients with T1 (n = 37) and T2 (n = 21) sinonasal SCCs, a risk score and a nomogram were generated. Results Only 5–10 % of respondents are performing END in T1 and 26–32% in T2 sinonasal SCCs. In our cohort regional recurrence was evident in 10 (17.2%) patients, representing a significant worse prognostic factor for cancer specific survival (HR 8.13; p = 0.016). Particularly, regional recurrence was more frequent in T2 tumors and in patients where the primary tumor originated from nasal septum and vestibule. Based on our clinical and questionnaire data a new risk-score was determined to predict necessity for END. The risk-score, including T-classification and tumor site, assigned T1-classification with 0 points, followed by 1 point for T2; tumor site: nasal septum or vestibule with 1 point and tumors from other subsites with 0 points. Based on these factors we further created a nomogram for predicting the risk of regional recurrence. Patients with a high-risk score showed 9.52-fold higher risk for regional and or distant recurrence (HR 9.52; p = 0.002;) and their 5-year CSS was 44.4% compared to 92.8% in patients with moderate or low risk (p = 0.017). Conclusions Our proposed risk-score system in T1-2N0 sinonasal carcinoma is helpful to identify patients who may benefit from END. Although to date END has no value in European head and neck cancer centers for T1-T2 sinonasal SCCs, our study indicates that the neck management in these patients should be reconsidered.


Sign in / Sign up

Export Citation Format

Share Document